Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-0043-05

The MDA system with MDA Antithrombin III MDA Heparin

bioMerieux, Inc. / initiated 2004-06-11 / Terminated

bioMerieux began a recall of The MDA system with MDA Antithrombin III MDA Heparin on . The reason FDA records is "The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens". As of , the recall status on record is Terminated.

Recall record

Recall number
Z-0043-05
Status
Terminated
Initiated
Posted
Terminated
Recalling firm
bioMerieux, Inc.
Product
The MDA system with MDA Antithrombin III MDA Heparin
Product code
JPA System, Multipurpose For In Vitro Coagulation Studies
Reason for recall
The firm received complaints regarding an observed bias in percent activity between capped and uncapped specimens.
FDA root cause
Other
Action
Consignees were initially notified by letter on June 11, 2004. A follow up letter was sent to consignees, via Fedex on July 9, 2004.
Distribution
Nationwide, Australia, Belgium, Brazil, Canada, China, Germany, Italy, Japan, Taiwan, UK
Product codes and lots
All product numbers